Bruker (NASDAQ:BRKR – Get Rating) posted its earnings results on Thursday. The medical research company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.09, Briefing.com reports. Bruker had a return on equity of 34.13% and a net margin of 11.72%. The firm had revenue of $685.30 million for the quarter, […]